Public investment in science has been a cornerstone of modern national development, shaping economic growth, security and societal wellbeing. The mobilisation of science during the Second World War transformed perceptions of scientific capability from academic curiosity to strategic national asset and led to sustained peacetime commitment and the institutionalisation of research funding. Governments subsequently created funding agencies, national laboratories and policy frameworks that sought to balance curiosity‑driven basic research with mission‑oriented applied programmes and innovation policy directed at technology transfer and measurable social impact. This account traces that arc from the Second World War to the present, examines why governments fund science, highlights major institutional shifts and case studies, and provides regional context for Africa with a particular focus on Southern Africa.
Governments have funded science for multiple, evolving reasons. National security featured prominently after wartime experience demonstrated that scientific advantage could determine strategic outcomes; states therefore maintain R&D capacity to anticipate, deter or respond to threats. Economic competitiveness is a further driver: knowledge creation fuels new industries, productivity gains and high‑value employment, while public funding reduces early‑stage risk and builds foundational capabilities. Public goods and societal welfare such as health, environmental resilience and infrastructure, also depend on state‑supported research. Finally, funding supports human capital and institutional capacity by underwriting graduate training, research careers and the infrastructure needed for long‑term innovation.
Before the war, research funding tended to be modest and dispersed, flowing largely from universities, philanthropy and national academies. The war years radically altered this landscape: large, mission‑driven programmes channelled substantial resources into cryptography, radar, antibiotics, materials science and early computing, and intense collaboration among government, universities and industry became routine. The Manhattan Project epitomised the wartime model where concentrated funding, dedicated facilities, multidisciplinary teams and rigorous project management delivered a focused technological outcome. Wartime success thus yielded two enduring lessons: science can be organised as a national capability, and sustained, predictable funding and institutional stewardship are essential to translate discovery into strategic and societal outcomes.
The postwar period institutionalised many wartime lessons. Vannevar Bush’s The Endless Frontier (1945) provided an intellectual foundation for sustained government investment in basic research, particularly at universities, and catalysed the creation and expansion of public funding mechanisms. National laboratories, ministries and agencies (for example the National Science Foundation) were developed to support long‑term discovery, graduate education and international scientific engagement. Governance innovations included merit‑based peer review for grants and a clearer delineation between basic and mission‑driven research, while national laboratories and dedicated institutes provided durable infrastructure for interdisciplinary work. Agencies sought to balance investigator‑initiated grants with strategic programmes tied to health, energy, environment and defence‑adjacent needs.
A common indicator of national commitment to research is gross domestic expenditure on R&D as a share of GDP (GERD % GDP). Illustrative anchors across the postwar and modern eras include the United States with postwar GERD of roughly 2.5–3.0% of GDP and around 3.1% in recent years; the United Kingdom typically in the 1.7–2.0% range in the late twentieth century; and Germany often around 2.8–3.3% across the late twentieth and early twenty‑first centuries. Precise annual values vary by source and year; long‑run series are available from the OECD and World Bank.
The Cold War reinforced the strategic importance of basic science, with defence‑funded centres and national laboratories nurturing breakthroughs in semiconductors, computing and materials science that later catalysed civilian industries. Over time policy attention broadened from discovery alone to creating national innovation ecosystems linking universities, industry and government to translate research into marketable technologies. Legal and policy changes accelerated commercialisation: the Bayh‑Dole Act (1980) in the United States, which permitted universities to patent and licence federally funded inventions, became a pivotal mechanism for university technology transfer, spin‑offs and private investment in academic innovations. Evaluation practices likewise matured, with performance metrics and programme evaluation becoming routine to ensure public funds delivered societal returns.
Globalisation expanded cross‑border collaboration, pooled investments and large multinational science programmes. International facilities and consortia, CERN being a prominent example which enabled countries to share the costs and benefits of frontier science while addressing global problems such as climate change and pandemics. Contemporary public funding typically comprises three interlinked domains: basic research supported through competitive grants and investigator‑led inquiry; applied R&D that is mission‑oriented and often procurement‑driven; and innovation supports such as technology transfer offices, incubators, public–private partnerships and early‑stage funding to de‑risk commercialisation.
Prominent programme case studies illustrate diverse policy approaches. DARPA’s high‑risk, high‑reward model catalysed transformative technologies and exemplifies an adaptive, programme‑centred approach to innovation. The Bayh‑Dole Act institutionalised university commercialisation and helped spawn an active start‑up ecosystem. Horizon Europe represents a major multiyear framework for cross‑border research in Europe that emphasises societal challenges and innovation ecosystems. Large international facilities like CERN exemplify how nations collaborate to sustain frontier science and share expertise. National agencies such as NSF, NIH and the ERC among them, continue to underwrite basic discovery through peer review while sponsoring interdisciplinary and strategic initiatives.
Africa’s research intensity has historically been lower than that of advanced economies, but the twenty‑first century has seen growing commitment and capacity. Southern Africa is the region’s most developed STI cluster, with South Africa serving as the principal anchor and neighbouring states displaying varied levels of investment and capability. Postcolonial decades emphasised the establishment of universities and research councils, but funding remained modest and sensitive to macroeconomic conditions. From the 1990s onwards regional policy efforts and economic reforms fostered STI policy development, postgraduate training and cross‑border cooperation; in recent decades South Africa’s NRF, Department of Science and Innovation and national research councils have underpinned a more institutionalised funding model, while Botswana, Namibia, Zambia and others have expanded coordination through national commissions, innovation hubs and partnerships with international donors.
Indicative GERD ranges across Southern Africa show South Africa typically around 0.7–0.9% of GDP, Botswana roughly 0.2–0.6%, and Namibia about 0.3–0.5%, with other SADC members generally lower and more volatile. These figures are indicative; UNESCO UIS and World Bank country series provide precise annual data. Policy implications for Southern Africa emphasise the need for multi‑year predictable funding to retain talent and sustain infrastructure, regional pooling of resources to create shared laboratories and data centres that overcome budgetary constraints, alignment of STI investments with development priorities—health, agriculture, energy and climate resilience—and a continued balance between international partnerships for capacity building and strengthening domestic funding and private investment for long‑term sustainability.
In conclusion, public funding for science has evolved from wartime mobilisation into a sophisticated, multi‑institutional innovation ecosystem. Governments persist in funding science because it underpins national security, economic competitiveness, public health and societal progress. Effective systems today maintain a balanced portfolio across basic science, applied development and innovation‑enabled outcomes, underpinned by robust governance, international collaboration and commitments to inclusivity and responsible innovation. Southern Africa’s STI journey illustrates both the challenges of scaling investment and the opportunities presented by regional collaboration, targeted capacity building and strategic alignment of research with development goals.